Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Atracurium Besylate

Known as: Atracurium dibesylate, Atracurium besilate, 1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium 
A synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The antiallergic agent bepotastine besilate is a nonsedating, second-generation H1-antagonist with high oral absorption and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
Review
2003
Review
2003
The physiological changes that occur with increasing age can have significant effects on the pharmacokinetics of neuromuscular… Expand
Is this relevant?
Review
2001
Review
2001
Rapacuronium bromide (rapacuronium; ORG-9487) is a nondepolarising muscle relaxant (NMBA) with a low potency [90% effective dose… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Background and objective To compare the effects on cardiovascular changes induced by tracheal intubation when small doses of… Expand
Is this relevant?
Review
1999
Review
1999
Cisatracurium besilate, one of the 10 stereoisomers that comprise atracurium besilate, is a nondepolarising neuromuscular… Expand
  • figure 1
Is this relevant?
1997
1997
Betotastine besilate (betotastine CAS 125602-71-3, TAU-284) is a novel antiallergic agent with histamine H1 receptor antagonistic… Expand
Is this relevant?
1996
1996
Atracurium besylate (AB) is supplied as a sterile, non‐pyrogenic aqueous solution for intravenous use. Hospitals pre‐fill… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
To ascertain the effects of chronic renal failure on the pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (a stereoisomer… Expand
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
1983
1983
The plasma decay of atracurium besylate was examined in two groups of six patients. Group I received atracurium 0.6 mg kg-1 and… Expand
  • figure 1
  • table I
  • table III
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1982
Highly Cited
1982
Atracurium, a new non-depolarizing neuromuscular blocking agent, was studied in 70 patients anesthetized with fentanyl… Expand
  • figure 1
  • table 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?